Pharma & Medical Manufacturing

Lower risk and leaner stock in pharma production

Logio partnered with Oncomed to review inventory capacities and stock management to prevent production outages in oncology drug manufacturing.

Outcome

Using value stream mapping, material criticality segmentation, and clear ordering parameters, the team reduced outage risk and freed capacity while cutting average stock levels.

Average stock reduced by

-0 pcs

Outage risk from input‑material quality reduced by

- 0%

Inventory capacity increased by

+ 0%

About Oncomed

Oncomed manufacturing a.s. is a Brno‑based contract development and manufacturing organization focused on aseptic oncology injectables and is a subsidiary of medac GmbH. The company was founded in 2010 and produces sterile cytostatic medicines for global customers.

Founded: 2010

Employees: 200–249 (2024)

Production: three lines operating in Brno as of 2025

Initial challenge

Oncomed faced a risk of production outage due to variable input‑material quality and needed to revise inventory capacities and stock management.

Project goal

Set clear, criticality‑based ordering parameters and controls, introduce a tool to manage material purchases, and reduce risk while increasing usable capacity.

Solution

Inventory risk reduction for Oncomed

Value stream mapping and tighter purchasing controls helped Oncomed halve outage risk and release capacity with 60,000 fewer pieces held in stock.

01

Mapped the end‑to‑end production

and logistics flow using value stream mapping to reveal bottlenecks and inefficiencies.

02

Segmented materials

by criticality and quality risk. Defined key parameters and control levels for ordering and reordering.

03

Designed a tool to manage

material purchases and control compliance.

04

Proposed an ecological material‑disposal

 route via upcycling.

 
 

Solutions implemented

Capacity Planning

Replenishment & Allocation Management

Process Mapping & Analysis

Impact

Less stock, lower outage risk, more capacity.

Lower average stock

Inventory reduced by 60,000 pieces, releasing working capital.

Reduced outage risk

50% reduction in risk linked to input‑material quality.

More capacity

Inventory capacities increased by 14%, improving production readiness.

Standardized control

Clear ordering parameters by material criticality ensured consistent replenishment

Protect your pharma production from material risk

If input‑material quality and stock levels threaten your output, we can help redesign parameters, purchasing controls, and inventory setup. Let’s talk about a focused program that lowers risk and frees capacity without adding complexity.

420

By submitting, you agree to our Privacy Policy and allow Logio to contact you.

We tackled many supply chain challenges

Centralized inventory for Izomat

Veritico Stock enabled centralized, data‑driven replenishment for 90k+ SKUs, saving time on orders and improving service levels across Izomat’s branch network.

Data‑driven inventory management across 37 branches

Show case study

Seasonal inventory optimization for Zeelandia

Veritico Stock helps Zeelandia manage strong seasonal demand, increasing product availability by 9 % while cutting stock working capital by 18 % and shortening turnover time by 36 % to 70 days. Transparent, forecast‑driven planning now connects purchasing, production, warehouse transfers and distribution in one process.

+9% product availability

−18% stock working capital

−36% inventory turnover time, down to 70 days

Show case study